MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer.

Sung Hwan LeeHo Kyoung HwangWoo Jung LeeChang Moo Kang

Published in: Cellular oncology (Dordrecht) (2021)

From our data we conclude that MCT4 may serve as a potential therapeutic target in resectable pancreatic cancer. The precision medicine strategy for resectable pancreatic cancer should be validated in a clinical setting with a prospective study design.

Keyphrases

locally advanced
liver metastases
human health
electronic health record
squamous cell carcinoma
risk assessment
radiation therapy
machine learning